Related Experiment Videos
Successful intraventricular thrombolysis during ventricular assist device support
Claudio Russo1, Anna Maria De Biase, Giuseppe Bruschi
1Department of Cardiology, Niguarda Hospital, Milan, Italy. cf.russo@tiscalinet.it
The Annals of Thoracic Surgery
|May 23, 2002
Summary
Intraventricular thrombolysis effectively and safely treated possible device thrombosis in patients with continuous flow mechanical circulatory support. This intervention offers a viable solution for complications in advanced heart failure patients awaiting transplantation.
Area of Science:
- Cardiology
- Medical Devices
- Surgical Procedures
Background:
- Mechanical ventricular assist devices (MVADs) are crucial for end-stage congestive heart failure.
- Despite advancements, MVADs present significant complication risks, including thrombosis.
- Continuous flow devices are widely used as a bridge to heart transplantation.
Observation:
- A patient experienced possible thrombosis of an implanted continuous flow device.
- Conventional treatments were considered, but intraventricular thrombolysis was pursued.
- The procedure involved targeted thrombolytic therapy within the ventricular assist device.
Findings:
- Intraventricular thrombolysis successfully resolved the suspected device thrombosis.
- The patient tolerated the procedure well, with no immediate adverse events.
- This demonstrates the efficacy and safety of intraventricular thrombolysis in this context.
Implications:
- Intraventricular thrombolysis represents a potential therapeutic strategy for MVAD thrombosis.
- This approach may improve outcomes for patients with mechanical circulatory support.
- Further research can validate this technique for broader clinical application in heart failure management.